The article presents clinical, laboratory, instrumental data in children with functional biliary dyskinesias. Studies were conducted for the period 2014–2018. on the clinical base of the National Center for Maternal and Child Welfare. The object of the study were 120 children from 7 to 14 years. It has been established that the formation of a symptom complex in most cases is ambiguous and develops against the background of various diseases that were previously experienced. The presence of a large variation in the duration of the disease indicates a delayed diagnosis of pathology. Determining the type of biliary dyskinesia allows you to choose the most effective treatment regimen.

The article provides an overview of one of the main methods of treatment of hemangiomas in children with β-blockers on the basis of National Center for Maternal and Child health. Reflected the experience of drug treatment Propranolol 122 children with lesions of different localization and with different sizes of hemangioma. The effective and safe outcome of this pathology from Propranolol therapy has been analyzed. It was concluded that improvement was achieved in all children with this treatment. The therapy with Propranolol has proven to be an effective and safe non-surgical method for treating hemangiomas in children.

The article presents data from a survey of 217 children with various manifestations of metabolic disorders. This study made it possible to identify children at risk of developing atherogenic diseases whose abdominal obesity has not yet reached critical values.

The study was conducted on the basis of the Department of Endocrinology of the National Center for the Protection of Motherhood and Childhood. Under the supervision, there were 217 children who were divided into two groups: children with metabolic syndrome and children with normal body weight. A comparative analysis of the indicators of physical development in children with metabolic syndrome revealed that all indicators of physical data were significantly higher in the main group, which was predicted when examining children with metabolic syndrome.

The article presents a retrospective analysis of case histories of 392 children and adolescents with 1 type diabetes from 2011 to 2018. The analysis found that 60 children and adolescents suffer from diabetic nephropathy (which composes 15%). It was revealed that mostly diabetic nephropathy occurs in boys, as well as disease duration of type 1 diabetes at the time of diagnosis of diabetic nephropathy was 5–10 years.